4//SEC Filing
Shaaltiel Yoseph 4
Accession 0001209191-10-041740
CIK 0001006281other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:00 PM ET
Size
6.6 KB
Accession
0001209191-10-041740
Insider Transaction Report
Form 4
Shaaltiel Yoseph
DirectorExecutive VP, R&D
Transactions
- Sale
Common Stock
2010-08-05$7.00/sh−48,408$338,856→ 768,373 total - Sale
Common Stock
2010-08-06$7.00/sh−4,619$32,333→ 763,754 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001385118
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 5:00 PM ET
- Size
- 6.6 KB